Skip to main content
Erschienen in: AIDS and Behavior 1/2008

01.01.2008 | Original Paper

Optimal Recall Period and Response Task for Self-Reported HIV Medication Adherence

verfasst von: Minyi Lu, Steven A. Safren, Paul R. Skolnik, William H. Rogers, William Coady, Helene Hardy, Ira B. Wilson

Erschienen in: AIDS and Behavior | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Self-reported measures of antiretroviral adherence vary greatly in recall time periods and response tasks. To determine which time frame is most accurate, we compared 3-, 7-day, and 1-month self-reports with data from medication event monitoring system (MEMS). To determine which response task is most accurate we compared three different 1-month self-report tasks (frequency, percent, and rating) to MEMS. We analyzed 643 study visits made by 156 participants. Over-reporting (self-report minus MEMS) was significantly less for the 1-month recall period (9%) than for the 3 (17%) or 7-day (14%) periods. Over-reporting was significantly less for the 1-month rating task (3%) than for the 1-month frequency and percent tasks (both 12%). We conclude that 1-month recall periods may be more accurate than 3- or 7-day periods, and that items that ask respondents to rate their adherence may be more accurate than those that ask about frequencies or percents.
Literatur
Zurück zum Zitat Apter, A. J., Cheng, J., Small, D., Bennett, I. M., Albert, C., Fein, D. G., et al. (2006). Asthma numeracy skill and health literacy. The Journal of Asthma, 43, 705–710.CrossRefPubMed Apter, A. J., Cheng, J., Small, D., Bennett, I. M., Albert, C., Fein, D. G., et al. (2006). Asthma numeracy skill and health literacy. The Journal of Asthma, 43, 705–710.CrossRefPubMed
Zurück zum Zitat Arnsten, J. H., Demas, P. A., Farzadegan, H., Grant, R. W., Gourevitch, M. N., Chang, C. J., et al. (2001). Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring. Clinical Infectious Diseases, 33, 1417–1423.CrossRefPubMed Arnsten, J. H., Demas, P. A., Farzadegan, H., Grant, R. W., Gourevitch, M. N., Chang, C. J., et al. (2001). Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring. Clinical Infectious Diseases, 33, 1417–1423.CrossRefPubMed
Zurück zum Zitat Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., et al. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 14, 357–366.CrossRefPubMed Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., et al. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 14, 357–366.CrossRefPubMed
Zurück zum Zitat Bangsberg, D. R., Hecht, F. M., Clague, H., Charlebois, E. D., Ciccarone, D., Chesney, M., et al. (2001). Provider assessment of adherence to HIV antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 26, 435–442.PubMed Bangsberg, D. R., Hecht, F. M., Clague, H., Charlebois, E. D., Ciccarone, D., Chesney, M., et al. (2001). Provider assessment of adherence to HIV antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 26, 435–442.PubMed
Zurück zum Zitat Bova, C. A., Fennie, K. P., Knafl, G. J., Dieckhaus, K. D., Watrous, E., & Williams, A. B. (2005). Use of electronic monitoring devices to measure antiretroviral adherence: Practical considerations. AIDS and Behavior, 9, 103–110.CrossRefPubMed Bova, C. A., Fennie, K. P., Knafl, G. J., Dieckhaus, K. D., Watrous, E., & Williams, A. B. (2005). Use of electronic monitoring devices to measure antiretroviral adherence: Practical considerations. AIDS and Behavior, 9, 103–110.CrossRefPubMed
Zurück zum Zitat Chesney, M. A., Ickovics, J., Hecht, F. M., Sikipa, G., & Rabkin, J. (1999). Adherence: A necessity for successful HIV combination therapy. AIDS, 13(Suppl A), S271–S278.PubMed Chesney, M. A., Ickovics, J., Hecht, F. M., Sikipa, G., & Rabkin, J. (1999). Adherence: A necessity for successful HIV combination therapy. AIDS, 13(Suppl A), S271–S278.PubMed
Zurück zum Zitat Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., et al. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient care committee and adherence working group of the outcomes committee of the adult AIDS clinical trials group (AACTG). AIDS Care, 12, 255–266.CrossRefPubMed Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., et al. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient care committee and adherence working group of the outcomes committee of the adult AIDS clinical trials group (AACTG). AIDS Care, 12, 255–266.CrossRefPubMed
Zurück zum Zitat Cohen, J. (1977). Statistical power analysis for the behavioral sciences. New York: Academic. Cohen, J. (1977). Statistical power analysis for the behavioral sciences. New York: Academic.
Zurück zum Zitat Deschamps, A. E., Graeve, V. D., Van, W. E, De, S. V., Vandamme, A. M., Van, V. K., et al. (2004). Prevalence and correlates of nonadherence to antiretroviral therapy in a population of HIV patients using Medication Event Monitoring System. AIDS Patient Care STDS, 18, 644–657. Deschamps, A. E., Graeve, V. D., Van, W. E, De, S. V., Vandamme, A. M., Van, V. K., et al. (2004). Prevalence and correlates of nonadherence to antiretroviral therapy in a population of HIV patients using Medication Event Monitoring System. AIDS Patient Care STDS, 18, 644–657.
Zurück zum Zitat Dykema, J., & Schaeffer, N. C. (2000). Events, instruments, and reporting errors. American Sociological Review, 65, 619–629.CrossRef Dykema, J., & Schaeffer, N. C. (2000). Events, instruments, and reporting errors. American Sociological Review, 65, 619–629.CrossRef
Zurück zum Zitat Estrada, C., Barnes, V., Collins, C., & Byrd, J. C. (1999). Health literacy and numeracy. JAMA, 282, 527.CrossRefPubMed Estrada, C., Barnes, V., Collins, C., & Byrd, J. C. (1999). Health literacy and numeracy. JAMA, 282, 527.CrossRefPubMed
Zurück zum Zitat Gaito, J. (1982) Measurement scales and statistics: Resurgence of an old misconception. Psychological Bulletin, 87, 564–567.CrossRef Gaito, J. (1982) Measurement scales and statistics: Resurgence of an old misconception. Psychological Bulletin, 87, 564–567.CrossRef
Zurück zum Zitat Gao, X., Nau, D. P., Rosenbluth, S. A., Scott, V., & Woodward, C. (2000). The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care, 12, 387–398.CrossRefPubMed Gao, X., Nau, D. P., Rosenbluth, S. A., Scott, V., & Woodward, C. (2000). The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care, 12, 387–398.CrossRefPubMed
Zurück zum Zitat Gazmararian, J. A., Baker, D. W., Williams, M. V., Parker, R. M., Scott, T. L., Green, D. C., et al. (1999). Health literacy among Medicare enrollees in a managed care organization. JAMA, 281, 545–551.CrossRefPubMed Gazmararian, J. A., Baker, D. W., Williams, M. V., Parker, R. M., Scott, T. L., Green, D. C., et al. (1999). Health literacy among Medicare enrollees in a managed care organization. JAMA, 281, 545–551.CrossRefPubMed
Zurück zum Zitat Giordano, T. P., Guzman, D., Clark, R., Charlebois, E. D., & Bangsberg, D. R. (2004). Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clinical Trials, 5, 74–79.CrossRefPubMed Giordano, T. P., Guzman, D., Clark, R., Charlebois, E. D., & Bangsberg, D. R. (2004). Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clinical Trials, 5, 74–79.CrossRefPubMed
Zurück zum Zitat Golbeck, A. L., Ahlers-Schmidt, C. R., Paschal, A. M., & Dismuke, S. E. (2005). A definition and operational framework for health numeracy. American Journal of Prevntive Medicine, 29, 375–376.CrossRef Golbeck, A. L., Ahlers-Schmidt, C. R., Paschal, A. M., & Dismuke, S. E. (2005). A definition and operational framework for health numeracy. American Journal of Prevntive Medicine, 29, 375–376.CrossRef
Zurück zum Zitat Grymonpre, R. E., Didur, C. D., Montgomery, P. R., & Sitar, D. S. (1998). Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly. The Annals of Pharmacotherapy, 32, 749–754.CrossRefPubMed Grymonpre, R. E., Didur, C. D., Montgomery, P. R., & Sitar, D. S. (1998). Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly. The Annals of Pharmacotherapy, 32, 749–754.CrossRefPubMed
Zurück zum Zitat Hogg, R. S., Heath, K. V., Yip, B., Craib, K. J., O’Shaughnessy, M. V., Schechter, M. T., et al. (1998). Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA, 279, 450–454.CrossRefPubMed Hogg, R. S., Heath, K. V., Yip, B., Craib, K. J., O’Shaughnessy, M. V., Schechter, M. T., et al. (1998). Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA, 279, 450–454.CrossRefPubMed
Zurück zum Zitat Liu, H., Golin, C. E., Miller, L. G., Hays, R. D., Beck, C. K., Sanandaji, S., et al. (2001). A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134, 968–977.PubMed Liu, H., Golin, C. E., Miller, L. G., Hays, R. D., Beck, C. K., Sanandaji, S., et al. (2001). A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134, 968–977.PubMed
Zurück zum Zitat Montori, V. M., Leung, T. W., Thompson, C. A., Chung, J. A., Capes, S. E., & Smith, S. A. (2004). Choice of risk representation to enable diabetes decision-making. Diabetes, 53(Suppl 2), A225. Montori, V. M., Leung, T. W., Thompson, C. A., Chung, J. A., Capes, S. E., & Smith, S. A. (2004). Choice of risk representation to enable diabetes decision-making. Diabetes, 53(Suppl 2), A225.
Zurück zum Zitat Montori, V. M., & Rothman, R. L. (2005). Weakness in numbers. The challenge of numeracy in health care. Journal of General Internal Medicine, 20, 1071–1072.CrossRefPubMed Montori, V. M., & Rothman, R. L. (2005). Weakness in numbers. The challenge of numeracy in health care. Journal of General Internal Medicine, 20, 1071–1072.CrossRefPubMed
Zurück zum Zitat Nieuwkerk, P. T., & Oort, F. J. (2005). Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: A meta-analysis. Journal of Acquired Immune Deficiency Syndromes: JAIDS, 38, 445–448.CrossRefPubMed Nieuwkerk, P. T., & Oort, F. J. (2005). Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: A meta-analysis. Journal of Acquired Immune Deficiency Syndromes: JAIDS, 38, 445–448.CrossRefPubMed
Zurück zum Zitat Oyugi, J. H., Byakika-Tusiime, J., Charlebois, E. D., Kityo, C., Mugerwa, R., Mugyenyi, P., et al. (2004). Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. Journal of Acquired Immune Deficiency Syndromes: JAIDS, 36, 1100–1102.CrossRefPubMed Oyugi, J. H., Byakika-Tusiime, J., Charlebois, E. D., Kityo, C., Mugerwa, R., Mugyenyi, P., et al. (2004). Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. Journal of Acquired Immune Deficiency Syndromes: JAIDS, 36, 1100–1102.CrossRefPubMed
Zurück zum Zitat Palella, F. J., Jr., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A. et al. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. The New England Journal of Medicine, 338, 853–860.CrossRefPubMed Palella, F. J., Jr., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A. et al. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. The New England Journal of Medicine, 338, 853–860.CrossRefPubMed
Zurück zum Zitat Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21–30.PubMed Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21–30.PubMed
Zurück zum Zitat Pearson, C. R., Simoni, J. M., Hoff, P., Kurth, A. E., & Martin, D. P. (2007). Assessing antiretroviral adherence via electronic drug monitoring and self-report: An examination of key methodological issues. AIDS Behavior, 11, 161–173.CrossRef Pearson, C. R., Simoni, J. M., Hoff, P., Kurth, A. E., & Martin, D. P. (2007). Assessing antiretroviral adherence via electronic drug monitoring and self-report: An examination of key methodological issues. AIDS Behavior, 11, 161–173.CrossRef
Zurück zum Zitat Peters, E., Vastfjall, D., Slovic, P., Mertz, C. K., Mazzocco, K., & Dickert, S. (2006). Numeracy and decision making. Psychological Science, 17, 407–413.CrossRefPubMed Peters, E., Vastfjall, D., Slovic, P., Mertz, C. K., Mazzocco, K., & Dickert, S. (2006). Numeracy and decision making. Psychological Science, 17, 407–413.CrossRefPubMed
Zurück zum Zitat Preston, C. C., & Colman, A. M. (2000). Optimal number of response categories in rating scales: Reliability, validity, discriminating power, and respondent preferences. Acta Psychologica, 104, 1–15.CrossRefPubMed Preston, C. C., & Colman, A. M. (2000). Optimal number of response categories in rating scales: Reliability, validity, discriminating power, and respondent preferences. Acta Psychologica, 104, 1–15.CrossRefPubMed
Zurück zum Zitat Rogers, W. H., Wilson, I. B., Bungay, K. M., Cynn, D. J., & Adler, D. A. (2002). Assessing the performance of a new depression screener for primary care (PC-SAD). Journal of Clinical Epidemiology, 55, 164–175.CrossRefPubMed Rogers, W. H., Wilson, I. B., Bungay, K. M., Cynn, D. J., & Adler, D. A. (2002). Assessing the performance of a new depression screener for primary care (PC-SAD). Journal of Clinical Epidemiology, 55, 164–175.CrossRefPubMed
Zurück zum Zitat Schaeffer, N. C., & Presser, S. (2003). The science of asking questions. Annual Review of Sociology, 29, 65–88.CrossRef Schaeffer, N. C., & Presser, S. (2003). The science of asking questions. Annual Review of Sociology, 29, 65–88.CrossRef
Zurück zum Zitat Schwartz, L. M., Woloshin, S., Black, W. C., & Welch, H. G. (1997). The role of numeracy in understanding the benefit of screening mammography. Annals of Internal Medicine, 127, 966–972.PubMed Schwartz, L. M., Woloshin, S., Black, W. C., & Welch, H. G. (1997). The role of numeracy in understanding the benefit of screening mammography. Annals of Internal Medicine, 127, 966–972.PubMed
Zurück zum Zitat Simoni, J. M., Kurth, A. E., Pearson, C. R., Pantalone, D. W., Merrill, J. O., & Frick, P. A. (2006). Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS Behavior, 10, 227–245.CrossRef Simoni, J. M., Kurth, A. E., Pearson, C. R., Pantalone, D. W., Merrill, J. O., & Frick, P. A. (2006). Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS Behavior, 10, 227–245.CrossRef
Zurück zum Zitat Townsend, J. T., Hu, G. G., & Evans, R. J. (1984). Modeling feature perception in brief displays with evidence for positive interdependencies. Perception and Psychophysics, 36, 35–49.PubMed Townsend, J. T., Hu, G. G., & Evans, R. J. (1984). Modeling feature perception in brief displays with evidence for positive interdependencies. Perception and Psychophysics, 36, 35–49.PubMed
Zurück zum Zitat Vanhove, G. F., Schapiro, J. M., Winters, M. A., Merigan, T. C., & Blaschke, T. F. (1996). Patient compliance and drug failure in protease inhibitor monotherapy. JAMA, 276, 1955–1956.CrossRefPubMed Vanhove, G. F., Schapiro, J. M., Winters, M. A., Merigan, T. C., & Blaschke, T. F. (1996). Patient compliance and drug failure in protease inhibitor monotherapy. JAMA, 276, 1955–1956.CrossRefPubMed
Zurück zum Zitat Wagner, G. J., Kanouse, D. E., Koegel, P., & Sullivan, G. (2004). Correlates of HIV antiretroviral adherence in persons with serious mental illness. AIDS Care, 16, 501–506.CrossRefPubMed Wagner, G. J., Kanouse, D. E., Koegel, P., & Sullivan, G. (2004). Correlates of HIV antiretroviral adherence in persons with serious mental illness. AIDS Care, 16, 501–506.CrossRefPubMed
Zurück zum Zitat Wagner, G. J., & Rabkin, J. G. (1999). Measuring medication adherence: Is assessment of missed doses sufficient? [letter]. AIDS, 13, 2491–2492.CrossRefPubMed Wagner, G. J., & Rabkin, J. G. (1999). Measuring medication adherence: Is assessment of missed doses sufficient? [letter]. AIDS, 13, 2491–2492.CrossRefPubMed
Zurück zum Zitat Walsh, J. C., Mandalia, S., & Gazzard, B. G. (2002). Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS, 16, 269–277.CrossRefPubMed Walsh, J. C., Mandalia, S., & Gazzard, B. G. (2002). Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS, 16, 269–277.CrossRefPubMed
Zurück zum Zitat Ware, J. J., Kosinski, M., & Keller, S. D. (1996). A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Medical Care, 34, 220–233.CrossRefPubMed Ware, J. J., Kosinski, M., & Keller, S. D. (1996). A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Medical Care, 34, 220–233.CrossRefPubMed
Zurück zum Zitat Wilson, I. B., Tchetgen, E., & Spiegelman, D. (2001). Patterns of adherence with antiretroviral medications: An examination of between-medication differences. Journal of Acquired Immune Deficiency Syndromes, 28, 259–263.PubMed Wilson, I. B., Tchetgen, E., & Spiegelman, D. (2001). Patterns of adherence with antiretroviral medications: An examination of between-medication differences. Journal of Acquired Immune Deficiency Syndromes, 28, 259–263.PubMed
Zurück zum Zitat Woloshin, S., Schwartz, L. M., & Welch, H. G. (2005). Patients and medical statistics. Interest, confidence, and ability. Journal of General Internal Medicine, 20, 996–1000.CrossRefPubMed Woloshin, S., Schwartz, L. M., & Welch, H. G. (2005). Patients and medical statistics. Interest, confidence, and ability. Journal of General Internal Medicine, 20, 996–1000.CrossRefPubMed
Metadaten
Titel
Optimal Recall Period and Response Task for Self-Reported HIV Medication Adherence
verfasst von
Minyi Lu
Steven A. Safren
Paul R. Skolnik
William H. Rogers
William Coady
Helene Hardy
Ira B. Wilson
Publikationsdatum
01.01.2008
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 1/2008
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-007-9261-4

Weitere Artikel der Ausgabe 1/2008

AIDS and Behavior 1/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.